当前位置：
X-MOL 学术
›
Circulation
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
Circulation ( IF 35.5 ) Pub Date : 2024-08-12 , DOI: 10.1161/circulationaha.124.069396 Antonio Abbate 1 , Benjamin Van Tassell 2 , Vlad Bogin 3 , Roshanak Markley 2 , Dmitry V Pevzner 4 , Paul C Cremer 5 , Imad Meray 6 , Dmitry V Privalov 7 , Angela Taylor 1 , Sergey A Grishin 8 , Alina N Egorova 8 , Ekaterina G Ponomar 8 , Yan Lavrovsky 9 , Mikhail Yu Samsonov 8 ,
中文翻译：
使用 RPH-104 (Goflikicept) 阻断 ST 段抬高型心肌梗死 (STEMI) 患者的国际双盲、随机、安慰剂对照 IIa 期研究结果。
更新日期：2024-08-12
Circulation ( IF 35.5 ) Pub Date : 2024-08-12 , DOI: 10.1161/circulationaha.124.069396 Antonio Abbate 1 , Benjamin Van Tassell 2 , Vlad Bogin 3 , Roshanak Markley 2 , Dmitry V Pevzner 4 , Paul C Cremer 5 , Imad Meray 6 , Dmitry V Privalov 7 , Angela Taylor 1 , Sergey A Grishin 8 , Alina N Egorova 8 , Ekaterina G Ponomar 8 , Yan Lavrovsky 9 , Mikhail Yu Samsonov 8 ,
Affiliation
中文翻译：
使用 RPH-104 (Goflikicept) 阻断 ST 段抬高型心肌梗死 (STEMI) 患者的国际双盲、随机、安慰剂对照 IIa 期研究结果。
京公网安备 11010802027423号